Next Quarterly Earnings
Date confirmed from the official Chinese exchange disclosure timetable.
Yunnan Baiyao Group A is a leading Chinese pharmaceutical company specializing in Traditional Chinese Medicine (TCM). It researches, develops, and produces innovative medicines and health products. The company globally distributes medical products and related consumer goods, showcasing its commitment to advancing healthcare through both traditional wisdom and modern scientific approaches.
Date confirmed from the official Chinese exchange disclosure timetable.
Yunnan Baiyao Group A is scheduled to report its next quarterly earnings on 08/29/2026.
Yunnan Baiyao Group A last reported quarterly earnings on 4/30/2026 (Q1 2026). Earnings per share (EPS) came in at 1.14 CNY.
Across its last 3 earnings reports, Yunnan Baiyao Group A stock moved by ±1.5% on average the following day. The largest reaction was -2.9% on 04/30/2026; 2 of 3 reactions were positive.
Yunnan Baiyao Group A has beaten analyst EPS estimates in 3 of its last 4 evaluated quarters (beat rate: 75%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.